| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |